FDG-PET/CT in the staging of local/regional metastases in breast cancer
被引:53
|
作者:
Robertson, Ian J.
论文数: 0引用数: 0
h-index: 0
机构:
Mater Misericordiae Univ Hosp, Eccles Breast Screening Unit, Dublin 7, IrelandMater Misericordiae Univ Hosp, Eccles Breast Screening Unit, Dublin 7, Ireland
Robertson, Ian J.
[1
]
Hand, Fiona
论文数: 0引用数: 0
h-index: 0
机构:
Mater Misericordiae Univ Hosp, Eccles Breast Screening Unit, Dublin 7, IrelandMater Misericordiae Univ Hosp, Eccles Breast Screening Unit, Dublin 7, Ireland
Hand, Fiona
[1
]
Kell, Malcolm R.
论文数: 0引用数: 0
h-index: 0
机构:
Mater Misericordiae Univ Hosp, Eccles Breast Screening Unit, Dublin 7, IrelandMater Misericordiae Univ Hosp, Eccles Breast Screening Unit, Dublin 7, Ireland
Kell, Malcolm R.
[1
]
机构:
[1] Mater Misericordiae Univ Hosp, Eccles Breast Screening Unit, Dublin 7, Ireland
FDG-PET/CT;
Breast cancer;
Local/regional metastases;
POSITRON-EMISSION-TOMOGRAPHY;
LYMPH-NODE BIOPSY;
MANAGEMENT;
SCAN;
D O I:
10.1016/j.breast.2011.07.002
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Breast cancer is the commonest female malignancy in the Western world and the most reliable predictor for survival is axillary lymph node metastases. Conventional staging techniques employed in breast cancer include mammography, ultrasonography, isotope bone scanning, sentinel lymph node biopsy, axillary lymph node dissection and magnetic resonance imaging. More recently FDG-PET and FDG-PET/CT have been used to complement the above methods. This review assesses the role of FOG-PET/CT in axillary staging ill patients with primary breast cancer. A PubMed search was conducted and all articles containing relevant or new information were included. Relevant studies examined identified that FOG-PET/CT has a sensitivity of 60% and a specificity of 97% in detecting lymphatic metastasis. Although positive axillary FOG-PET/CT is a good predictor of axillary disease and correlates well with SLNB, the relatively poor sensitivity (60%) must be considered for treatment planning. (C) 2011 Elsevier Ltd. All rights reserved.
机构:
Queen Mary Univ London, Dept Nucl Med, London, England
Queen Mary Univ London, Inst Canc Mol Oncol & Imaging, London, EnglandQueen Mary Univ London, Dept Nucl Med, London, England
Avril, Norbert
Mather, Stephen J.
论文数: 0引用数: 0
h-index: 0
机构:
Queen Mary Univ London, Dept Nucl Med, London, England
Queen Mary Univ London, Inst Canc Mol Oncol & Imaging, London, EnglandQueen Mary Univ London, Dept Nucl Med, London, England
Mather, Stephen J.
Roylance, Rebecca
论文数: 0引用数: 0
h-index: 0
机构:
Queen Mary Univ London, Barts & London NHS Trust, Dept Med Oncol, London, England
Queen Mary Univ London, Inst Canc Mol Oncol & Imaging, London, EnglandQueen Mary Univ London, Dept Nucl Med, London, England
机构:
St Louis Hosp, Dept Nucl Med, Paris, France
Univ Paris Diderot, INSERM U976, HIPI, Paris, France
Ctr Imagerie Radio Isotop, La Rochelle, France
St Louis Hosp, Assistance Publ Hop Paris, Dept Nucl Med, 1 Ave Claude Vellefaux, F-75475 Paris 10, FranceSt Louis Hosp, Dept Nucl Med, Paris, France
机构:
St Louis Hosp, Dept Nucl Med, Paris, France
Univ Paris Diderot, INSERM, CNRS, UMR944 7212, Paris, FranceSt Louis Hosp, Dept Nucl Med, Paris, France